Research On Market Value Influencing Factors Of Pharmaceutical Chain Enterprises Based On Qualitative Comparative Analysis

As the most intuitive embodiment of the internal value of an enterprise,the market value is not only an important indicator to judge the overall strength of the enterprise,but also one of the goals of the long-term operation and development of the enterprise.At the same time,under the background of the comprehensive implementation of various policies such as pharmaceutical separation and two-invoice system,China’s pharmaceutical chain industry is facing huge development opportunities.In terms of the several listed pharmaceutical chain enterprises,with the rapid growth in recent years,the performance of the enterprise market value has appeared very obvious differences.Therefore,this paper takes the four listed pharmaceutical chain enterprises in China as the object,explore the relevant factors affecting the market value of enterprises,combine the theory of market value management,and get the relevant enlightenment to improve the market value of pharmaceutical chain enterprises.This paper first sorts out the existing relevant literature from the two aspects of enterprise market value and market value management,and analyzes and compares the relevant factors affecting the market value of enterprises combined with the characteristics of pharmaceutical chain enterprises.Then on this basis,join the fuzzy set qualitative comparative analysis(fs QCA),from 2016 to 2020 listed pharmaceutical chain companies as a sample,selected the equity concentration,institutional investors holdings,executives in the master’s ratio and enterprise net assets earnings four indicators,using qualitative comparative analysis,studied the relationship between the indicators and enterprise market value performance.With the traditional regression method is very different,this paper found that the factors affecting the enterprise market value performance,not alone,but with certain configuration influence the enterprise market value performance,respectively the pharmaceutical chain enterprise performance of a combination structure,low market value performance of three combination structure,and respectively discusses the various configuration reflected in the pharmaceutical chain enterprise market value management problems.Finally,combined with the relevant factors affecting the market value of the enterprise,the enlightenment to improve the market value management of pharmaceutical chain enterprises.This paper analyzes the related factors affecting the pharmaceutical chain market value,and using qualitative comparative analysis,to explore the factors affecting the pharmaceutical chain market value high,low performance path,not only for the existing pharmaceutical chain enterprise market value management has certain significance,also for the future research causal complexity research opens a new field of vision.